CONTEXT: Physical exercise-related stress activates hypothalamus-pituitary-adrenal (HPA) axis; nitric oxide is one of the mediators of the HPA axis response to stress, and phosphodiesterase type 5 inhibitors influences nitric oxide-linked biological activities. OBJECTIVE: The objective of the study was to investigate whether a single oral long half-life phosphodiesterase type5 inhibitor (tadalafil) administration influences the HPA axis response to exercise-related stress. DESIGN: This was a double-blind, cross-over trial. PARTICIPANTS: Participants included nine healthy male athletes. INTERVENTIONS: All subjects performed a maximal exercise test in normoxia, after which they received a single oral administration of tadalafil or placebo. Then after a 2-wk washout period, they were crossed over and repeated the exercise test. Each subject was his own control. Salivary collections, for steroid evaluations [cortisol, dehydroepiandrosterone sulphate (DHEAS), testosterone] and respective ratio calculation (DHEAS to cortisol, testosterone to cortisol, testosterone to DHEAS), were performed before each exercise (Pre-Ex), immediately after (Post-Ex), and at 30 min during recovery. RESULTS: As expected, mean salivary cortisol concentration increased immediately after exercise after both tadalafil and placebo (P = 0.014 and P =0.036 vs. Pre-Ex, respectively); however, the cortisol increase was significantly higher after tadalafil administration (P = 0.034 vs. placebo). Furthermore, an increased salivary testosterone after exercise was observed only after tadalafil administration (P = 0.029 vs. Pre-Ex). No effects of either exercise and/or tadalafil administration on salivary DHEAS concentrations were observed. DHEAS to cortisol and testosterone to cortisol ratios significantly decreased after exercise after tadalafil administration (P = 0.037, and P = 0.02 vs. placebo, respectively). CONCLUSION:Tadalafil administration amplified the salivary cortisol and testosterone responses to a maximal exercise-related stress in healthy trained humans.
RCT Entities:
CONTEXT: Physical exercise-related stress activates hypothalamus-pituitary-adrenal (HPA) axis; nitric oxide is one of the mediators of the HPA axis response to stress, and phosphodiesterase type 5 inhibitors influences nitric oxide-linked biological activities. OBJECTIVE: The objective of the study was to investigate whether a single oral long half-life phosphodiesterase type 5 inhibitor (tadalafil) administration influences the HPA axis response to exercise-related stress. DESIGN: This was a double-blind, cross-over trial. PARTICIPANTS: Participants included nine healthy male athletes. INTERVENTIONS: All subjects performed a maximal exercise test in normoxia, after which they received a single oral administration of tadalafil or placebo. Then after a 2-wk washout period, they were crossed over and repeated the exercise test. Each subject was his own control. Salivary collections, for steroid evaluations [cortisol, dehydroepiandrosterone sulphate (DHEAS), testosterone] and respective ratio calculation (DHEAS to cortisol, testosterone to cortisol, testosterone to DHEAS), were performed before each exercise (Pre-Ex), immediately after (Post-Ex), and at 30 min during recovery. RESULTS: As expected, mean salivary cortisol concentration increased immediately after exercise after both tadalafil and placebo (P = 0.014 and P =0.036 vs. Pre-Ex, respectively); however, the cortisol increase was significantly higher after tadalafil administration (P = 0.034 vs. placebo). Furthermore, an increased salivary testosterone after exercise was observed only after tadalafil administration (P = 0.029 vs. Pre-Ex). No effects of either exercise and/or tadalafil administration on salivary DHEAS concentrations were observed. DHEAS to cortisol and testosterone to cortisol ratios significantly decreased after exercise after tadalafil administration (P = 0.037, and P = 0.02 vs. placebo, respectively). CONCLUSION:Tadalafil administration amplified the salivary cortisol and testosterone responses to a maximal exercise-related stress in healthy trained humans.
Authors: C Fantini; P Sgrò; M Pittaluga; A de Perini; I Dimauro; A Sartorio; D Caporossi; L Di Luigi Journal: J Endocrinol Invest Date: 2017-02-16 Impact factor: 4.256
Authors: F Marampon; C Antinozzi; C Corinaldesi; G B Vannelli; E Sarchielli; S Migliaccio; L Di Luigi; A Lenzi; C Crescioli Journal: Endocrine Date: 2017-08-07 Impact factor: 3.633
Authors: Guglielmo Duranti; Roberta Ceci; Paolo Sgrò; Stefania Sabatini; Luigi Di Luigi Journal: Cell Stress Chaperones Date: 2017-03-11 Impact factor: 3.667
Authors: P Sgrò; C Minganti; M Lista; C Antinozzi; M Cappa; Y Pitsiladis; F Pigozzi; L Di Luigi Journal: J Endocrinol Invest Date: 2020-09-18 Impact factor: 4.256
Authors: Antonio Aversa; Simona Fittipaldi; Davide Francomano; Viviana M Bimonte; Emanuela A Greco; Clara Crescioli; Luigi Di Luigi; Andrea Lenzi; Silvia Migliaccio Journal: Endocrine Date: 2017-01-30 Impact factor: 3.633
Authors: P Sgrò; F Romanelli; F Felici; M Sansone; S Bianchini; C F Buzzachera; C Baldari; L Guidetti; F Pigozzi; A Lenzi; L Di Luigi Journal: J Endocrinol Invest Date: 2014-01-08 Impact factor: 4.256
Authors: Luigi Di Luigi; Francesco Botrè; Stefania Sabatini; Massimiliano Sansone; Monica Mazzarino; Laura Guidetti; Carlo Baldari; Andrea Lenzi; Daniela Caporossi; Francesco Romanelli; Paolo Sgrò Journal: Endocrine Date: 2014-02-15 Impact factor: 3.633